Aimmune is the second initial public offering of stock this week from the Bay Area
Made For
Aimmune is the second initial public offering of stock this week from the Bay Area
Ashpool has identified 1 product used by Aimmune Therapeutics
Ashpool has identified the primary mail recipient on this domain as ProofPoint
Format | Success Rate |
flast@aimmune.com |
|
firstl@aimmune.com |
|